AVENUE SOLUTIONS

Lobbying for INCYTE CORPORATION · Biopharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Delaware · House · Senate · $60,000.00 income · posted Oct 20, 2025

Lobbying activity 2

Health Issues

Issues related to 340b; Expiring healthcare extenders

Medicare/Medicaid

Issues related to Medicaid rebates; Issues related to Most Favored Nation (MFN) drug pricing proposal

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.